Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Explore which performs better: index funds or mutual funds, focusing on costs, tracking error, and long-term results for investors.
24,353 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A notable fund pulled out of a multi-million dollar DNOW position last quarter, triggering questions about strategy a...
When yields rise, even patient investors can feel the pressure. This guide explains what rising treasury yields spook...
When a tech giant faces a costly lawsuit over a celebrity image, it isn’t just a legal story—it’s a personal finance ...
Growth-focused SPYG has outpaced SPYV over the last decade, a trend supported by AI spending and mega-cap tech. The g...
A growing share of households are adopting financial minimalism as markets stay volatile in 2026. The approach favors...
Market rallies can mask drift in your asset mix. Learn why right now is a great moment to rebalance and how to do it ...
As teens head into summer jobs, experts say disciplined saving and smart investing can transform a paycheck into deca...
A new generation rewrites the wealth playbook, stacking income streams and investing smarter as traditional paths gro...
Germany plans sweeping changes to its pension system in 2026. This article breaks down what the reforms could mean fo...
A blunt six-word warning from a top hedge fund founder has traders and investors rethinking AI hype. This article bre...
Is XRP still worth considering today? This guide dives into timing, risk, and practical entry strategies for investor...